D P Swanson
Overview
Explore the profile of D P Swanson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
688
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Federle M, Willis L, Swanson D
J Comput Assist Tomogr
. 1998 Jun;
22(3):341-5.
PMID: 9606371
Purpose: The purpose of our study was to evaluate the effect of bolus infusion of contrast medium (ionic versus nonionic) on the incidence of nausea and anaphylactoid reactions. Method: We...
3.
Mokotoff M, Swanson D, Jonnalagadda S, Epperly M, Brown M
J Pept Res
. 1997 Jun;
49(6):510-6.
PMID: 9266478
The laminin peptide fragments GYIGSR-NH2 and CDPGYIGSR-NH2 are known to bind to a 67-kDa laminin receptor. This receptors is understood to be expressed at higher than normal levels in malignant...
4.
CALLAHAN R, Chilton H, Goodwin D, Hnatowich D, Ponto J, Swanson D, et al.
J Nucl Med
. 1996 Dec;
37(12):2092-4.
PMID: 8970541
No abstract available.
5.
Swanson D
Semin Nucl Med
. 1996 Apr;
26(2):91-5.
PMID: 8723503
Rare diseases and conditions are defined as diseases or conditions that affect less than 200,000 individuals in the United States. Because of the limited population suffering from any given rare...
6.
Hieronim D, Kanal E, Swanson D
Am J Health Syst Pharm
. 1995 Nov;
52(22):2556-9.
PMID: 8590239
Compliance with an institution's dosage guidelines for gadoteridol was determined, and adverse reactions to gadoteridol and gadopentetate were compared. Departmental policy in March 1993 set the standard dose of gadoteridol...
7.
8.
Damiani D, Swanson D
Am J Hosp Pharm
. 1994 Feb;
51(3):358-63.
PMID: 8160688
A pharmacist-managed program for reporting, treating, and monitoring adverse drug reactions (ADRs) to contrast media is described. The radiology pharmacist at a 1000-bed multihospital medical center worked with the radiology...
9.
Damiani D, Swanson D, Hanwell L
Am J Hosp Pharm
. 1993 Jun;
50(6):1204-6.
PMID: 8517462
No abstract available.
10.
BUSH W, Swanson D
AJR Am J Roentgenol
. 1991 Dec;
157(6):1153-61.
PMID: 1950858
Acute, potentially life-threatening systemic reactions to contrast media are less frequent with lower osmolality, nonionic contrast agents, but they are not totally eliminated. Severe reactions remain a reality in all...